Interestingly, XNT treatment dose-dependently reduced CDK2 expression in the colon cancer cell HCT116 [54], suggesting CDK2 may be indirectly involved for XNT to display its broad antiviral activity. This evidence concerns the gene CDK2 and colonic neoplasm.